Citigroup Maintains Buy on Bio-Techne, Raises Price Target to $80
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Patrick Donnelly maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $70 to $80.
Citigroup analyst Patrick Donnelly maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $70 to $80.